Open access
Aug 2026
First Antibacterial Evaluation of an Anthraquinone–triphenylphosphonium Conjugate (SH1) against Sensitive and Drug-resistant Staphylococcus aureus and Escherichia coli
The results identify SH1 as a previously uncharacterised antibacterial agent active against MRSA and support the anthraquinone–DLC pharmacophore as a membrane-active scaffold warranting further structural optimisation.
Victor Arinze Orajekwe
· Journal of applied chemical... · 0 citations